RxDoctor Payments Data

Do Nguyen

Optometrist · Memphis, TNNPI 1407114663

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.8%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Alcon at 35.6% of the total. Reporting peaked in 2023 at $2,112 and has fallen 79.1% since, to $442 in 2025. Among optometrist clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,831in general payments, 2019–2025

Across 51 payments — averaging $114.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • Biotissue Holdings Inc.$2K
  • AbbVie$414
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$356
  • Johnson & Johnson Vision Care, Inc.$238
  • Genentech USA, Inc.$132
  • plus $712 from 8 others

What the payments were for

  • Travel & lodging$3,02252%
  • Food & beverage$2,79048%
  • Gifts$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,831 in reported general payments places this provider in the 95th percentile of 1,122 optometrist providers in Tennessee.

See all optometrist providers in Tennessee

Medicare billing

Part B allowed, 2024
$25,222
Medicare patients
108
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Travoprost18$4,047
Brimonidine Tartrate23$342
Latanoprost43$339
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat11$268
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha17$168

Paid to pharmacies, not to this prescriber.

Other optometrist in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →